Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3730 | allogeneic mesenchymal stem cell Wiki | 0.71 |
drug2490 | Placebo Wiki | 0.03 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.03 |
D018352 | Coronavirus Infections NIH | 0.02 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There are 2 clinical trials
This is a randomized (4:1) Phase 1 b safety trial in SARS CoV-2 negative subjects at high risk for infection.
Description: Safety will be measured and tabulated by the number (percent) of participants who experience DLTs (grade 3/4 adverse events) from the start of therapy through the end of the follow up period (day 91), according to DAIDS.
Measure: Safety and tolerability, Dose Limiting Toxicity Time: 91 daysDescription: Determining the effect on local and systemic inflammatory markers through blood collection and collection of nasal mononuclear cells
Measure: Assess the response of the body to the study drug (pharmacodynamics) Time: 91 daysThis is a randomized (4:1) Phase 1 b safety trial in SARS CoV-2 negative subjects at high risk for infection.
Description: Safety will be measured and tabulated by the number (percent) of participants who experience DLTs (grade 3/4 adverse events) from the start of therapy through the end of the follow up period (day 91), according to DAIDS.
Measure: Safety and tolerability, Dose Limiting Toxicity Time: 91 daysDescription: Determining the effect on local and systemic inflammatory markers through blood collection and collection of nasal mononuclear cells
Measure: Assess the response of the body to the study drug (pharmacodynamics) Time: 91 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports